Insulin resistance syndrome including obesity, hyperglycemia, hyperlipidemia, and hypertension or insulin therapy in our donors might interfere with the insulin signaling pathway, leading to alteration of the INSR function (43). The gene discussed is INSR; the disease is hyperlipidemia.